This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Authors Of Healthcare At A Turning Point Discuss How To Enact Real Reform

PHOENIX, March 29, 2013 /PRNewswire/ -- In their new book, Healthcare at a Turning Point, Dr. Rita Numerof and Michael Abrams examine the state of healthcare, why it is failing, and how to fix it.

In minutes, these experts can explain:
  • The single most important factor driving healthcare inflation, and what successful reform of the system requires that's currently missing
  • Why accountable care organizations are more likely to damage our healthcare system further than to result in lower costs or better quality
  • What the implications of the current reform path are for healthcare innovation in the US
  • What the unanticipated consequences of the current approach to reform are likely to look like
  • Why a market-based approach to healthcare reform is the key to genuine change

Dr. Numerof and Mr. Abrams will be in Phoenix April 3, and are available for meetings and interviews.

About Dr. Rita Numerof

An internationally recognized consultant, Rita works in dynamic industries like healthcare that are challenged to develop new business models to adapt to major market changes. Rita's expertise has helped a wide range of leading companies to fundamentally reshape and execute new strategy. Her global cross-industry perspective and expertise in strategy execution are the basis for objective counsel that leading executives tap into on a regular basis. She is widely published in business journals and has authored five books, including Healthcare at a Turning Point: A Roadmap for Change.

About Michael Abrams

Over the past 25 years, Michael has built a portfolio of strategy and business performance successes as both an internal and external consultant for Fortune 500 corporations on a global basis. Michael is well known for his expertise in the emerging demand for economic and clinical value, and has helped clients develop processes and capabilities to successfully compete in highly dynamic markets. Michael has written extensively on the need for integrated, systemic solutions to the challenges facing the healthcare industry, and has co-authored two books, including Healthcare at a Turning Point: A Roadmap for Change.

SOURCE Numerof

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs